ROS-scavenging hydrogel to accelerate wound healing and reduce scar formation
Deviating from the recommended dosage, whether intentionally or accidentally, can compromise the therapeutic efficacy and lead to unintended consequences
Acknowledgment This study was funded by Kyowa Hakko Bio (Tokyo, Japan)
As the next phase of this research, more sophisticated in vivo models, incorporating chronic injury paradigms, long-term follow-ups, and genetic or pharmacological modifications of inflammatory pathways, will be critical to substantiate the translational potential of this approach
For context on what these results look like in practice, tirzepatide before and after results and male-specific tirzepatide transformations show real outcomes across different dose levels